Medicinova (MNOV) Retained Earnings (2010 - 2026)
Medicinova (MNOV) posted quarterly Retained Earnings of -$438.7 million for Q4 2025, down 2.81% year-over-year from -$451.4 million in Q4 2024, and down 0.64% quarter-over-quarter from -$435.9 million in Q3 2025.
Medicinova (MNOV) Retained Earnings (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Retained Earnings for 16 consecutive years, with -$438.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings fell 2.81% year-over-year to -$438.7 million; the TTM figure through Dec 2025 stood at -$438.7 million (down 2.81% YoY), while the FY2025 annual figure was -$438.7 million, down 2.81% from the prior year.
- Retained Earnings fell to -$438.7 million in Q4 2025 per MNOV's latest filing, from -$435.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$93677.0 in Q2 2021 and bottomed at -$438.7 million in Q4 2025.
- Historically, Retained Earnings has averaged -$189.1 million across 5 years, with a median of -$129254.5 in 2024.
- Annual changes were most pronounced in 2021 — Retained Earnings jumped 99.97% — and 2022, when it slumped 427407.83%.
- Medicinova's Retained Earnings stood at -$98877.0 in 2021, then fell by 16.59% to -$115285.0 in 2022, then plunged by 360486.11% to -$415.7 million in 2023, then dropped by 2.66% to -$426.8 million in 2024, then decreased by 2.81% to -$438.7 million in 2025.
- Business Quant data shows MNOV's Retained Earnings at -$438.7 million in Q4 2025, -$435.9 million in Q3 2025, and -$432.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | -443.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -443.65 Mn |
| Dec 31, 2025 | -438.75 Mn |
| Sep 30, 2025 | -435.95 Mn |
| Jun 30, 2025 | -432.90 Mn |
| Mar 31, 2025 | -429.62 Mn |
| Dec 31, 2024 | -426.75 Mn |
| Sep 30, 2024 | -123,803.00 |
| Jun 30, 2024 | -131,527.00 |
| Mar 31, 2024 | -126,982.00 |
| Dec 31, 2023 | -415.70 Mn |
| Sep 30, 2023 | -123,752.00 |
| Jun 30, 2023 | -121,040.00 |
| Mar 31, 2023 | -116,827.00 |
| Dec 31, 2022 | -115,285.00 |
| Sep 30, 2022 | -404.13 Mn |
| Jun 30, 2022 | -400.48 Mn |
| Mar 31, 2022 | -396.45 Mn |
| Dec 31, 2021 | -98,877.00 |
| Sep 30, 2021 | -95,039.00 |
| Jun 30, 2021 | -93,677.00 |